Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-09-19

Clinical Trial Update: Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

View source ↗

Summary

An observational study evaluating tamsulosin in patients with benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Status: COMPLETED